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Genome editing, also known as gene editing, is a technique of genetic engineering that 
involves the alteration of an organism’s genetic structure by adding, deleting, changing or 
replacing individual nucleotides or sequences of DNA.1 Genome editing includes several 
different methods and tools, which can be used by breeders to alter the traits of crop 
plants and livestock animals. Genome-edited crops and food products are beginning to 
be commercialised, which raises questions around how the techniques and products of 
genome editing should be governed.
This briefing discusses the governance of genome editing and its products in the 
European Union (EU). The future of the EU’s rules could have significant implications for 
agricultural and food systems within the European single market, for the bloc’s trading 
relations with the USA and other countries, and for African countries that want to export 
agricultural products to European markets. The EU has been under pressure from within 
and without to change its current approach. Stakeholders from science and industry 
argue that European regulators should adopt a more permissive approach. Foreign 
governments, notably the United States, argue that the EU’s rules governing genetic 
engineering techniques are excessively restrictive and constitute a barrier to trade. 
However, environmentalists and consumer groups insist that stringent regulation of 
genetic engineering technologies is appropriate, justified and democratically legitimate. 
Introduction
1 DNA stands for deoxyribonucleic acid, a type of molecule often referred to as the genetic ‘building blocks’ of life.
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The EU has wrestled for several years with 
the question, whether genome editing should 
be regulated in the same way as the previous 
generation of genetic engineering techniques. 
In July 2018, the European Court of Justice (ECJ) 
ruled that genome-edited organisms should be 
governed under the same rules and protocols 
that govern the cultivation and marketing of 
genetically modified organisms (GMOs) within 
the single market. These rules adhere to the 
precautionary principle and impose special rules 
for GMOs, including measures for approval, 
monitoring, labelling and liability. The court’s 
decision rejected an alternative proposition: that 
genome-edited organisms should be considered 
comparable to crop varieties developed using 
conventional breeding techniques, including 
mutagenesis, a procedure that uses chemicals or 
radiation to induce genetic mutations (see Briefing 
1). The ECJ concluded that “organisms obtained 
by mutagenesis are GMOs”, but excluded those 
“which have conventionally been used in a number 
of applications and have a long safety record”.
The legal frameworks governing genetically 
engineered organisms in the EU include Directive 
2001/18/EC, which regulates the deliberate 
release of GMOs; Regulation (EC) 1829/2003 
concerning genetically modified food and feed; 
Regulation (EC) 1830/2003, which establishes 
rules on the traceability and labelling of GMOs; 
and Directive (EU) 2015/412, which governs the 
scope for EU member states to restrict or prohibit 
the cultivation of GMOs in their territory. Council 
Directive 2002/53/EU, on the common catalogue 
of varieties of agricultural plant species, embraces 
both conventional plants and GMOs. The diagram 
in Box 1 delineates the instruments under which 
GMOs, genome-edited organisms and mutagenic 
organisms are regulated in the EU.
Background
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Box 1. Mapping the EU legal framework for deliberate release of seeds, 
and the implication of the 25 July 2018 ECJ Ruling
Key – text taken verbatim from :
Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 
on the deliberate release into the environment of genetically modified organisms and 
repealing Council Directive 90/220/EEC - Commission Declaration
Council Directive 2002/53/EC of 13 June 2002 on the common catalogue of varieties 
of agricultural plant species
Judgement of the Court (Grand Chamber) 25 July 2018, Case C-528/16
2002/53: “Varieties of agricultural plant species of those varieties of beet, 
fodder plant, cereal, potato and fibre plant the seed of which may be marketed”
2001/18: “genetically modified organism (GMO) means an organism, with 
the exception of human beings, in which the genetic material has been 
altered in a way that does not occur naturally by mating and/or natural 
recombination” (including inter alia those techniques in Annex I A, part 1 
but not Annex I A, part 2)
Source: GEAP3 project.
Included in 2001/18: “organisms obtained by means of techniques/
methods of mutagenesis constitute GMOs”
Exempt from 2001/18: “organisms obtained by means 
of techniques/methods of mutagenesis which have 
conventionally been used in a number of applications and have 
a long safety record”
The diagram shows the scope 
and exemptions of different 
EU Directives relating to seed 
(indicated by the colour of the text 
– see key below). Implications of 
the ruling of the court with respect 
to deliberate release are indicated 
by the blue surrounding line. On the 
basis of the ruling, genome-edited 
crops fall within the shaded area.
Although not shown in the 
diagram, inclusion and exemption 
from Directive 2001/18 is identical 
to inclusion and exemption from 
Regulation (EC) 1829/2003, (EC) 
1830/2003, and (EU) 2015/412.
The ECJ ruling brought legal clarity but attracted 
a range of reactions from different stakeholders. 
It was welcomed by people and groups that 
express concerns about genome editing, because 
it adhered to the precautionary principle. 
The international peasant organisation La Vía 
Campesina, for instance, celebrated the decision as 
a “historic victory for peasants and citizens of the 
EU”, while the European Network of Scientists for 
Social and Environmental Responsibility (ENSSER) 
also welcomed the court’s ruling.
Proponents of genome editing techniques, on the 
other hand, saw the ruling as prohibitive. Scientists 
expressed concern that embracing genome editing 
within the legal framework for GMOs would create 
an impossible situation for regulators, because of 
the technical difficulty of detecting genome edited 
organisms. The German science academies and 
the German Research Foundation (DFG) argue, 
for instance, that European regulations hamper 
the development of “urgently needed improved 
crops to support productive, climate adapted 
and sustainable agriculture”. The European seed 
industry organisation Euroseeds complained 
that the ECJ ruling made genome editing tools 
“unavailable for European plant breeding and 
agriculture”. 
Debates about the future regulation of 
genome editing are still ongoing in the EU. The 
Netherlands, for instance, proposed a change of 
EU regulation in 2018 with the aim of exempting 
genome editing at least partly from GMO 
regulation. Fourteen EU member states called 
for a “unified approach” that could exempt some 
genome editing techniques or products from the 
GMO rules. Business organisations have called for 
a move to more “innovation-friendly” regulations, 
including less complex approval procedures. On 
8 November 2019, the European Commission was 
requested by the EU member states to study “the 
status of novel genomic techniques under Union 
law”. The results of this inquiry are expected in 
Spring 2021. A key issue is how EU rules could 
affect imported agricultural products, because 
genome editing is already being used in some 
countries that export goods to the EU single 
market, such as the USA (see below).
Debates about the ruling
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At least two different pathways can be identified for 
the future of genome editing policy and regulatory 
frameworks in the EU. The first path represents the 
status quo following the ECJ ruling of July 2018: in 
other words, the continuing regulation of genome-
edited products as GMOs in the EU, including 
the application of strict rules on risk assessment, 
labelling and traceability. The history of agricultural 
GMOs in the EU suggests that this pathway would 
make approval of new genome-edited organisms 
for commercial use in European agriculture quite 
unlikely. The most extensively planted GM crop 
variety in Europe, a transgenic maize variety called 
MON810, has been cultivated only in a few EU 
member states. The great majority of cropland in 
the EU has remained GMO-free, with some member 
states and regions opting out of the cultivation of 
MON810 and other GM crops.
A second pathway would involve changing EU 
rules, for example, so that some or all genome-
editing applications would be regulated in similar 
ways as ‘conventional’ breeding techniques 
(including mutagenesis), i.e. less restrictively than 
GMOs, with less stringent requirements on risk 
assessment, traceability and labelling. Proponents 
of genome editing argue for this outcome by 
highlighting technical distinctions between 
genome editing and the first generation of GMOs. 
They believe that these differences could allow 
genome editing and its products to be perceived as 
less controversial in Europe (see Briefing 1).
Under either of these scenarios, the option 
for individual member states to approve (new) 
techniques of genetic engineering in their 
territories could lead to the development of 
‘genome editing hotspots’ in Europe. It appears 
that the governments of some EU member states 
do favour allowing the cultivation of GMOs and 
genome-edited crops, as the proposal by the 
Netherlands suggests. 
Evidence suggests that strong coalitions exist 
across Europe which would resist genome editing 
in agriculture, no matter how the technology 
is framed by proponents or policy makers. 
Eurobarometer public opinion surveys indicate 
that most European citizens remain opposed to 
GMOs, although recent studies are less clear – 
possibly because the topic of genetic engineering 
has not been high on the public agenda in recent 
years. Nevertheless, it can be expected that 
conflicts over genome editing will escalate if and 
when commercial applications begin. The history 
of GMO conflicts suggests that contestation over 
genome editing is likely to be more intense for 
food rather than animal feed. Divergences in public 
opinion among individual EU member states might 
amplify the tendency for genome editing hotspots 
to emerge in specific countries or locations. 
Divergences in national policy and practice 
on genome editing could pose a challenge for 
the integration of the EU’s single market. The 
potential for friction among member states may be 
exacerbated by upcoming reforms of the Common 
Agricultural Policy (CAP) and the implementation 
of the European Commission’s proposed Farm-
to-Fork Strategy for agriculture and food, which 
promotes biotechnology as a key tool for  
achieving sustainability.
The future of genome editing in the EU
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Disagreements over the need for traceability and 
labelling were at the heart of historical disputes 
between the EU and the USA over the regulation 
of GMOs. In the early 2000s, these disagreements 
led to a formal dispute in the World Trade 
Organisation (WTO), in which the USA claimed that 
the EU was illegally restricting its exports of GM 
products without providing sufficient scientific 
evidence of harm (the complaint was upheld). 
GMOs were also a key issue during unsuccessful 
efforts to negotiate a Transatlantic Trade and 
Investment Partnership (TTIP) between the EU and 
USA in the 2010s. These contestations over GMO 
governance are likely to be replayed over genome 
editing. Some American farmers have been 
cultivating a genome-edited rapeseed (canola) 
variety (‘Falco’ from the company Cibus) since 
2015 and the possibility of importing this crop into 
the EU remains uncertain. In May 2020, the USA 
took further steps towards the deregulation of 
GMOs and genome editing technologies. Efforts 
by European regulators to control the flow of 
genome-edited crop varieties into the EU could be 
complicated by the current difficulty of identifying 
some products of genome editing using existing 
detection techniques.
Genome editing and transatlantic trade relations
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The United Kingdom’s departure from the EU  
on 31 January 2020 may eventually lead to the UK 
diverging from EU regulations on biotechnology  
in agriculture, with implications for the application 
of genome editing in agriculture and for UK—
EU trade in agricultural inputs and products 
(see Briefing 3). The UK’s absence from the EU’s 
internal negotiations about regulation might 
affect the balance of forces towards a stricter 
regulation in the EU, even if there remain other 
member states within the EU that that are likely 
to continue pushing for more permissive rules. If 
the UK decides to allow cultivation of GMOs and 
genome-edited crops, this might reinforce the 
EU’s model of mostly GM-free production on one 
hand, while on the other hand creating frictions in 
trade between the EU and the UK.
Genome editing and the EU after Brexit
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The EU is an important market for agricultural 
products from sub-Saharan Africa and also an 
important aid donor and source of technical 
cooperation for some African countries. This 
means that EU policies and regulations that 
govern genome editing in agriculture and food 
could influence African nations that export 
agricultural products to Europe, as well as those 
that participate in EU-funded aid and technical 
cooperation programmes affecting agriculture 
and technology. Of the GM crops currently grown 
around the world, few have had any commercial 
potential to be cultivated in African countries for 
export to European countries. The situation could 
be different for genome editing techniques, if they 
are applied to the improvement of horticultural 
crops, for example, which are produced in Africa 
for European consumers.
EU and sub-Saharan Africa
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The GEAP3 Project Policy Hub
The Genome Editing and Agriculture: Policy, Practices and Public Perceptions (GEAP3) network is an 
international research consortium that brings together social scientists, policy experts and bio-scientists to 
explore the domestic and international ramifications of the EU’s policy and regulatory approach to genome 
editing in agriculture. The network is exploring and analysing key developments in genome editing and their 
implications for agriculture through three hubs: policy, practice, and public perceptions.
The GEAP3 Policy hub is exploring systematically the implications of the EU’s regulatory approach to genome 
editing. The hub is examining how competing visions for the governance of genome editing conflict or may be 
reconciled. For further information on the GEAP3 network and the Policy hub, please visit the project website at 
https://www.geap3.com
Other GEAP3 briefings in this series
Briefing 1:  Genome Editing in Agriculture: Issues for Policy and Regulation
Briefing 3:  Genome Editing in Agriculture: Regulation in the United Kingdom after Brexit
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